IDEAS home

Printed from https://ideas.repec.org/s/ohe/monogr.html

My serials Follow this serial

Office of Health Economics

Monograph

Contact information of Office of Health Economics

Postal:

Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT

Phone: +44 (0) 20 7747 1440
Fax: +44 (0) 20 7691 7355
Web page: https://www.ohe.org/
Email:

More information through EDIRC

Serial Information

Series handle: RePEc:ohe:monogr

Citations RSS feed: at CitEc

Impact factors

Access and download statistics
Top item:

By citations
By downloads (last 12 months)

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:monogr. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

Content

2020

002287 How Should the World Pay for a COVID-19 Vaccine?
by Adrian Towse
002255 The Evolution of US Policy Responses to the Opioid Epidemic
by Richard G. Frank

2019

002090 Can a Strong Economic Case Be Made for Investing in the NHS?
by Peter Smith

2017

001860 Ten Years of the NIHR: Achievements and Challenges for the Next Decade
by Dame Sally C. Davies

2015

001664 Cost-per-QALY in the US and Britain: Damned if You Do and Damned if You Don’t
by Milton Weinstein
001571 Universal Health Coverage: The Holy Grail?
by Anne Mills

2013

000036 What constitutes credible evidence of effectiveness
by Michael Rawlins
000035 The challenges and economics of drug development in 2022
by Nancy Mattison
000003 OHE Guide to UK Health and Health Care Statistics
by Emma Hawe;Lesley Cockcroft

2012

000135 The R&D Cost of a New Medicine
by Jorge Mestre-Ferrandiz;Jon Sussex;Adrian Towse

2011

000189 Incorporating Multiple Criteria in HTA: Methods and Processes
by Nancy Devlin;Jon Sussex
000184 New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
by Priya Sharma;Adrian Towse
000179 Achieving World Class Outcomes in Cancer Treatment
by Sir Mike Richards
000176 Using Happiness to Value Health
by Paul Dolan

2010

000221 Measuring Health Output, Productivity and Equity: Future Challenges
by Anthony Atkinson
000220 Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making
by Nancy Devlin;John Appleby
000218 US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?
by Alan M. Garber
000204 Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
by Phill O’Neill
000195 Biosimilars: How Much Entry and Price Competition Will Result?
by Adrian Towse;Nancy Mattison;Jorge Mestre-Ferrandiz

2008

000244 NHS Outcomes, Performance and Productivity
by Deven Chauhan
000243 QALYs versus Experience: A Perspective from Experimental Economics
by Daniel Kahneman

2007

000264 The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?
by Jean Stephenne

2006

000270 Health Systems Performance Assessment
by Christopher Murray
000268 Economic Post-Launch Studies: Matching the Desirable with the Feasible
by Anne R. Mason;Michael F. Drummond;Adrian Towse
000266 Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance
by Kenneth Arrow;Richard Peto

2005

000272 Childhood and Adolescent Mental Health: Understanding the Lifetime Impacts
by Tara St. John;Lucy Leon;Andrew McCulloch

2004

000493 To Publish or Not: Experience and Evidence About Publishing Hospital Outcomes Data
by Anne R. Mason;Andrew Street
000491 The Economics of Dental Care
by Ray Robinson;Darshan Patel;Rowena Pennycate
000490 How Much Should We Spend on the NHS?
by John Appleby;Nancy Devlin;Diane Dawson
000489 What Could be Nicer than NICE?
by Alan Williams
000488 The Impact of Ageing on Health Care Expenditures: Impending Crisis, or Misguided Concern?
by Meena Seshamani
000487 Activity Based Funding for Hospitals: English Policy, International Experience
by Andrew Street

2003

000486 To Heal and Harm: An Economic View of Drug Safety
by Jonathan Silcock;Clive Pritchard
000485 Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments
by Andrew Briggs
000483 Quality in Primary Care: Economic Approaches to Analysing Quality-Related Physician Behaviour
by Michael Kuhn
000481 Institutions for Industrial Competitiveness in the International Pharmaceutical Industry
by Jorge Mestre-Ferrandiz;Jon Sussex

2002

000480 The Life Cycle of Pharmaceuticals: A Cross-National Perspective
by Patricia Danzon;Jeong Kim
000479 Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
by Hannah Kettler;Adrian Towse
000477 Interpreting and Addressing Inequalities in Health: From Black to Acheson to Blair to . . . ?
by Robert Evans
000476 Influencing Prescribing in a Primary Care Led NHS
by Anne R. Mason;Michael F. Drummond;Jonathan Cooke;Adrian Towse
000475 Health Economics: An Introduction to Economic Evaluation
by Gisela Kobelt
000474 Disability Adjusted Life Years (DALYs) for Decision-Making?
by Julia Fox-Rushby
000473 Cost-Effectiveness Thresholds: Economic and ethical issues
by Clive Pritchard;Nancy Devlin;Adrian Towse

2001

000472 Why Care About Health Inequality?
by Adam Oliver
000471 The Links of Public Health and Economic Development
by Jeffrey Sachs
000470 The Economics of the Private Finance Initiative in the NHS
by Office of Health Economics
000469 Don’t Look Back? Voluntary and Charitable Finance of Hospitals
by John Mohan;Martin Gorsky
000468 Consolidation and Competition in the Pharmaceutical Industry
by Hannah Kettler
000467 Capturing the Unexpected Benefits of Medical Research
by Clive Pritchard

2000

000466 The Road to Sustainability in the UK and German Biotechnology Industries
by Steven Casper;Hannah Kettler
000465 Surgical Research and Development in the NHS - Promotion, Management and Evaluation
by Katharine Johnston
000464 Productivity Costs: Principles and Practice in Economic Evaluation
by Clive Pritchard;Martin Sculpher
000463 Primary Care and the NHS Reforms: A Manager’s View
by Robert Royce
000462 Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
by Patricia Danzon;Li-Wei Chao
000461 Narrowing the Gap between provision and need for medicines in developing countries
by Hannah Kettler
000460 Managing to do Better: General Practice in the 21st Century
by Gordon Moore
000459 Improving Population Health in Industrialised Nations
by Office of Health Economics
000458 Health Care without Frontiers?
by Lyndsay Mountford
000457 Benchmarking and Incentives in the NHS
by Paul Grout;Andrew Jenkins;Carol Propper

1999

000456 Updating the Cost of a New Chemical Entity
by Hannah Kettler
000455 Trade Mark Legislation and the Pharmaceutical Industry
by Shelley Lane;Jeremy Phillips
000453 Risk and Return in the Pharmaceutical Industry
by Nick Marchant
000452 Risk Adjusting Health Care Resource Allocations
by Adam Oliver
000450 Organisational Costs in the New NHS
by Bronwyn Croxson
000448 Genomics, Healthcare and Public Policy
by Paul Williams;Sarah Clow
000447 Doctors, Economics and Clinical Practice Guidelines: Can they be brought together?
by David M. Eddy
000446 Disease Management, the NHS and the Pharmaceutical Industry
by Anne R. Mason;Michael F. Drummond;Adrian Towse

1998

000443 Our Certain Fate: Rationing in Health Care
by Alan Maynard;Karen Bloor
000442 National Health Service Reorganisation: Learning from History?
by Charles Webster
000441 Managed Care - An Option for the German Health Care System?
by Robert Seitz;Hans-Helmut Konig;Eleni Jelastopulu
000440 Managed Care - A Model for the UK?
by Peter West
000437 Effective Commissioning: Lessons from purchasing in American managed care
by Donald W. Light
000435 Controlling NHS Expenditure: The Impact of Labour’s NHS White Papers
by Office of Health Economics
000434 Competition through Innovation, Innovation through Competition
by Hannah Kettler
000433 Competition and contestability between acute hospitals
by Office of Health Economics
000432 Biotechnology and the Economics of Discovery in the Pharmaceutical Industry
by Helen Simpson
000431 Accountable Health Care: Is it compatible with social solidarity?
by Uwe Reinhardt

1997

000430 Trade and Price Differentials for Pharmaceuticals: Policy Options
by Patricia Danzon
000429 Theory and Evidence on Cost Sharing in Health Care: An Economic Perspective
by Martin Chalkley;Ray Robinson
000425 NHS Waiting Lists: Towards the Elusive Solution
by Rhiannon Tudor Edwards
000423 Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
by Adrian Towse
000421 Drivers of the Growth in Medicines Expenditure
by Nick Marchant

1996

000420 Using Consumer Preferences in Health Care Decision Making: The Application of Conjoint Analysis
by Mandy Ryan
000419 Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
by Brian Rittenhouse
000418 The Future of Primary Care
by Jane Griffin
000417 The Doctor's (Ethical and Economic) Dilemma
by David L. Sackett

1995

000415 Value of the Pharmaceutical Industry to the UK Economy
by David Hale;Adrian Towse
000414 Industrial Policy and the Pharmaceutical Industry
by Adrian Towse
000413 Hypothecated Health Taxes: An evaluation of recent proposals
by Andrew Jones;Alan Duncan
000412 Health Information and the Consumer
by Jane Griffin
000411 Health Care as a Handicraft Industry
by William J. Baumol
000409 Financing Health Care in the UK: A Discussion of NERA’s Prototype Model to Replace the NHS
by Adrian Towse

1994

000405 Managing the NHS: past, present and agenda for the future
by William Laing
000402 A Doctor Looks at Health Economics
by Sir Douglas Black

1993

000400 Science in Medicine: How Far Has It Advanced?
by George Teeling Smith;Cynthia Roberts

1992

000397 Innovative Competition in Medicine
by George Teeling Smith

1991

000394 AIDS: Worldwide Policies and Problems
by Mildred Blaxter

1990

000377 Measuring the Benefits of Medicines: The Future Agenda
by George Teeling Smith

1989

000373 People as Patients and Patients as People
by Office of Health Economics
000370 Holes in Therapy
by Christopher C. Booth

1988

000366 Measuring Health: a Practical Approach
by George Teeling Smith
000365 Innovative Chemical Extensions: The Economic Basis of Pharmaceutical Progress
by Nick Wells
000361 Economic Evaluation and Develop Medicines in the Development of Medicines
by Michael F. Drummond;George Teeling Smith;Nick Wells

1987

000358 Health Economics: Prospects for the Future
by George Teeling Smith
000357 Cost and Benefits of Pharmaceutical Research
by George Teeling Smith

1986

000351 Health, Education and General Practice
by George Teeling Smith

1985

000652 Pharmaceuticals in seven nations
by Robert Chew;George Teeling Smith;Nick Wells
000346 Techniques of Health Status Measurement Using a Health Index
by Gillian Holland

1984

000647 Pharmaceuticals in Developing Countries 1981-82
by Office of Health Economics
000344 Patterns of European Diagnoses and Prescribing
by Bernie O'Brien
000342 New NHS Act for 1996?
by George Teeling Smith

1983

000341 Second Pharmacological Revolution
by Office of Health Economics
000340 Future for Pharmaceuticals: the Potential; the Pattern and the Problems
by George Teeling Smith
000339 Consumer Movement, Health, and the Pharmaceutical Industry
by David Taylor
000338 Pharmaceuticals in Developing Countries
by Arnold Worlock
000336 Measuring the Social Benefits of Medicine
by George Teeling Smith
000334 Issues in Development: a Guide
by Klaus M. Leisinger
000333 Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s
by George Teeling Smith

1982

000326 Adverse Reactions and the Community
by George Teeling Smith

1981

000321 Health Research in England: Topic for Debate
by David Taylor
000320 Economic Aspects of the Development of New Medicines
by George Teeling Smith

1980

000314 Medicines: 50 Years of Progress 1930-1980
by Nick Wells
000309 Question of Balance: the Benefits and Risks of Pharmaceutical Innovation
by George Teeling Smith

1979

000301 Medicines for the year 2000
by George Teeling Smith;Nick Wells

1978

000283 Pharmaceutical Prices: A continental view
by Klaus von Grebmer

1977

000276 Sources of Information for Prescribing Doctors in Britain
by Office of Health Economics

1976

000260 Brand Names in Prescribing
by Office of Health Economics

1975

000256 Canberra Hypothesis: the Economics of the Prescription Medicine Market
by Office of Health Economics

1972

000223 Pharmaceutical Industry and Society: a Study of the Changing Environment and Economics of the International Industry
by George Teeling Smith
000207 Evaluation in the Health Services
by Office of Health Economics

1970

000646 Pharmaceuticals Among the Sunrise Industries
by Nick Wells

1969

000170 Medicines in the 1990s: a Technological Forecast
by Office of Health Economics
000164 Innovation in Industry: a Factor for Growth
by Office of Health Economics
000163 Human Relations in General Practice
by John McKenzie
000161 Economics and Innovation the Pharmaceutical Industry
by George Teeling Smith

1968

000150 Consumer and the Health Service
by John McKenzie

1967

000147 Provision of General Medical Care in New Towns
by Dr John Fry;John McKenzie
000137 Innovation Balance of Payments: the Experience of the Pharmaceutical Industry
by George Teeling Smith
000133 Alive to Forty-Five
by George Teeling Smith

1966

000131 Women in Medicine: The Results of an Inquiry Conducted by the Medical Practitioners' Union in 1962 – 63
by Margot Jefferys;Patricia M. Elliott
000129 Surveillance and Early Diagnosis and General Practice
by George Teeling Smith

1965

000122 Residue of Poliomyelitis
by Michael Lee
000119 Science, Industry in the State
by George Teeling Smith

1963

000101 Health Services in Western Europe
by Office of Health Economics

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.